Literature DB >> 26045828

TNF-α-308G/A polymorphism associated with TNF-α protein expression in patients with diabetic nephropathy.

Yan Peng1, Liu-Juan Li1.   

Abstract

AIMS: This study was to clarify the regulated effects of TNF-α -308G/A polymorphism on TNF-α and investigate the relationship of -308G/A polymorphisms with diabetic nephropathy (DN) susceptibility.
METHODS: 86 DN patients and 94 healthy individuals were enrolled in our study. Polymerase chain reaction-sequence specific primer (PCR-SSP) detection technology was used to testify single nucleotide polymorphism (SNP) of TNF-α gene. Enzyme-linked immunosorbent assay (ELISA) was used to measure the content of TNF-α protein. Odds ratio (OR) with 95% CI were used to evaluate the association of TNF-α -308G/A polymorphism and DN susceptibility.
RESULTS: The level of TNF-α protein was much higher in DN patients compared to that of controls (P<0.05). For TNF-α -308G/A, G/A genotype could increase the risk for DN (OR=2.15, 95% CI=1.08-4.30). Moreover, a allele frequency was found higher in cases compared with controls, which suggested that A allele served as an genetic-susceptibility factor for DN (OR=1.89, 95% CI=1.10-3.26). Further analysis indicated that level of TNF-α for individuals with mutant genotype (GA and AA) were higher than that of individuals with wild genotype (P<0.05). However, AA genotype showed no effects on DN susceptibility (OR=2.08, 95% CI=0.56-7.33).
CONCLUSION: TNF-α-308G/A polymorphism was associated with expression level of TNF-α and served as an genetic-susceptibility factor for DN.

Entities:  

Keywords:  Tumor necrosis factor-α; diabetic nephropathy; protein expression

Mesh:

Substances:

Year:  2015        PMID: 26045828      PMCID: PMC4440137     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

Review 1.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  [Inflammation, prelude to renal sclerosis: the importance of NF-kappa B].

Authors:  Laurent Baud; Bruno Fouqueray; Agnès Bellocq; Jean-Philippe Haymann; Julie Peltier
Journal:  J Soc Biol       Date:  2002

3.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

4.  Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection.

Authors:  Cheng-Chan Lu; Bor-Shyang Sheu; Ten-Wen Chen; Hsiao-Bai Yang; Kuey-Hsian Hung; Ai-Wen Kao; Chiao-Hsiung Chuang; Jiunn-Jong Wu
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

5.  Cellular events in the evolution of experimental diabetic nephropathy.

Authors:  B A Young; R J Johnson; C E Alpers; E Eng; K Gordon; J Floege; W G Couser; K Seidel
Journal:  Kidney Int       Date:  1995-03       Impact factor: 10.612

6.  Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

Authors:  Juan F Navarro; Francisco J Milena; Carmen Mora; Candelaria León; Felix Claverie; Carlos Flores; Javier García
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

7.  Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.

Authors:  G E Caughey; L G Cleland; J R Gamble; M J James
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

8.  The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Authors:  L A Tartaglia; R F Weber; I S Figari; C Reynolds; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  [Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis].

Authors:  F Kacprzyk; W Chrzanowski
Journal:  Pol Arch Med Wewn       Date:  1996-09

10.  Urinary tumor necrosis factor levels in primary glomerulopathies.

Authors:  S Ozen; U Saatci; K Tinaztepe; A Bakkaloglu; A Barut
Journal:  Nephron       Date:  1994       Impact factor: 2.847

View more
  6 in total

1.  TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing spondylitis in Chinese Han population.

Authors:  Nai-Guo Wang; Da-Chuan Wang; Bing-Yi Tan; Feng Wang; Ze-Nong Yuan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Rhein lysinate protects renal function in diabetic nephropathy of KK/HlJ mice.

Authors:  Ya-Jun Lin; Yong-Zhan Zhen; Jing-Bo Wei; Jie Wei; Jing Dai; Jun-Ling Gao; Kai-Ji Li; Gang Hu
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

3.  Serum profile of cytokines and their genetic variants in metabolic syndrome and healthy subjects: a comparative study.

Authors:  Uzma Zafar; Saba Khaliq; Hafiz Usman Ahmad; Khalid Pervaiz Lone
Journal:  Biosci Rep       Date:  2019-02-01       Impact factor: 3.840

4.  MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD).

Authors:  Marco Guarneri; Letizia Scola; Rosa Maria Giarratana; Manuela Bova; Caterina Carollo; Loredana Vaccarino; Leonardo Calandra; Domenico Lio; Carmela Rita Balistreri; Santina Cottone
Journal:  Genes (Basel)       Date:  2022-01-25       Impact factor: 4.096

5.  Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Authors:  Jukka Partanen; Kati Hyvärinen; Heike Bickeböller; Katarzyna Bogunia-Kubik; Rachel E Crossland; Milena Ivanova; Francesca Perutelli; Ralf Dressel
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

6.  Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome.

Authors:  Dalia Ghareeb; Abdallah S Abdelazem; Ekhlas M Hussein; Amira S Al-Karamany
Journal:  J Diabetes Metab Disord       Date:  2021-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.